Log In or Register to Join The Conversation!
Viewing 0 reply threads
  • Author
    Posts
    • #17124

      Thank you to everyone who signed, wrote a statement, and shared this effort. There has been 38,000 signatures and we are in our last week (deadline is January 20th)!

      Click here to read and sign the letter: http://www.curefa.org/advocacy

      *This letter requests Reata to submit a New Drug Application (NDA) on an urgent basis and FDA to exercise the flexibility granted by law and contained in FDA guidance in considering approval of an NDA for Omaveloxolone in FA based on the existing evidence from clinical trials.*

      qq

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2021 All rights reserved.

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account